2 reports

  • R&D Progress

R& D Progress Research and Development Brief Adipotide Product Description Adipotide (Prohibitin TP-##, Prohibitin targeting peptide-##) is under development for the treatment of castrate resistant prostate cancer.

  • Pharmaceutical
  • Research And Development
  • United States
  • Company Operations
  • Arrowhead Research Corporation

R& D Progress Research and Development Brief Company reported that the drug candidate has demonstrated superior activity in tumors where PD-## monotherapy or PD-##/ LAG-## monoclonal antibody combo has shown activity.

  • Immunotherapy
  • Monoclonal Antibody
  • Research And Development
  • Therapy
  • MacroGenics, Inc.